Skip to main content

Herman Ford Staats

Professor of Pathology
Pathology
Duke Box 3712, Durham, NC 27710
346M, Davison Building, Trent Drive, Durham, NC

Selected Grants


A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029

Duke KURe Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2013 - 2028

Perinatal Per- and Polyfluoroalkyl Substances (PFAS) exposure and Immunotoxicity

ResearchInvestigator · Awarded by National Institute of Environmental Health Sciences · 2023 - 2028

Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025

Research Training in Allergy and Clinical Immunology

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2000 - 2025

A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029

Duke KURe Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2013 - 2028

Perinatal Per- and Polyfluoroalkyl Substances (PFAS) exposure and Immunotoxicity

ResearchInvestigator · Awarded by National Institute of Environmental Health Sciences · 2023 - 2028

Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025

Research Training in Allergy and Clinical Immunology

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2000 - 2025

Adjuvant Comparison for Peanut Allergy Immunotherapy

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025

Basic Immunology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025

Developing RNA Vaccines to Treat Peanut Hypersensitivity

ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2025

A novel vaccination strategy to curb recUTIs

ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2024

Vaccine Adjuvant Discovery Program

ResearchPrincipal Investigator · Awarded by University of Montana · 2019 - 2024

CIVICS Component A - Option 4

ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2024

Duke CTSA (TL1) Year 5

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024

Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose

ResearchPrincipal Investigator · Awarded by University of New Mexico · 2021 - 2024

Gonorrhea Vaccine Cooperative Research Center (GV-CRC); Core C: Host Response Monitoring

ResearchInvestigator · Awarded by Henry M. Jackson Foundation · 2019 - 2024

Supramolecular peptide immunotherapies for peanut allergy

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2023

Rational Design of Transferrin Binding Protein-based Vaccines to Combat Gonorrhea

ResearchPrincipal Investigator · Awarded by Georgia State University · 2019 - 2023

Transmission electron microscope (TEM)

EquipmentMajor User · Awarded by National Institutes of Health · 2019 - 2021

Developing a SARS-CoV-2 subunit vaccine for nasal immunization

ResearchCollaborator · Awarded by North Carolina Biotechnology Center · 2020 - 2021

Evaluation of Conjugated VesiVax Formulations for HIV Vaccines

ResearchPrincipal Investigator · Awarded by Molecular Express, Inc. · 2020 - 2021

Design and Engineering of VesiVax HIV Immunogen Formulations

ResearchPrincipal Investigator · Awarded by Molecular Express, Inc. · 2020 - 2021

Evaluation of VesiVax Adjuvant Formulations for HIV Vaccines

ResearchPrincipal Investigator · Awarded by Molecular Express, Inc. · 2019 - 2021

Immunotherapy to combat skin infections

ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2021

Adjuvant Discovery Program (Option #3)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2020

Self-replicating RNA Vaccine for HIV-1 Delivered using a Nanoparticle Adjuvant Formulation

ResearchPrincipal Investigator · Awarded by PAI Life Sciences · 2019 - 2020

Novel Adjuvants and Carriers for Opiod Vaccines

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2020

Organization and Function of Cellular Structure

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2020

Core C: Monitoring Host Response

ResearchCo Investigator · Awarded by Henry M. Jackson Foundation · 2014 - 2020

Adjuvant Discovery Program (Option #2)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2019

Development of a Peanut Allergy Immunotherapy

ResearchPrincipal Investigator · Awarded by Molecular Express, Inc. · 2017 - 2019

Rational design of transferrin binding protein-based vaccines to combat gonorrhea

ResearchPrincipal Investigator · Awarded by Virginia Commonwealth University · 2017 - 2019

Pregnant rabbits as a model to evaluate the causative role of ZIKV infection in the etiology of congenital malformations

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2018

Selection of a VesiVax vaccine for West Nile Virus

ResearchPrincipal Investigator · Awarded by Molecular Express, Inc. · 2017 - 2018

Understanding the Mechanism of Mucosal Immunotherapy

ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2012 - 2018

Serial Block Face Scanning Electron Microscope

EquipmentMinor User · Awarded by National Institutes of Health · 2016 - 2018

Overcoming Immunosenescence by Nanoparticle-Mediated Activation

ResearchCo Investigator · Awarded by Columbia University · 2017 - 2018

Adjuvant Discovery Program (Option #1)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2017

Innate immune adaptations of hibernation as a new approach to protection against acute organ injury

ResearchCo-Mentor · Awarded by Society of Cardiovascular Anesthesiologists · 2015 - 2017

Mucosal vaccination to protect against HIV-1 infection at mucosal sites

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2017

Adjuvant Discovery Program

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2017

Study protocol 8. TrichGuard and TrichGuard V5L LCM project (Option B)

ResearchPrincipal Investigator · Awarded by Boehringer Ingelheim Vetmedica, Inc. · 2016 - 2016

Development of VesiVax Carbohydrate Conjugation Chemistry

ResearchPrincipal Investigator · Awarded by Molecular Express, Inc. · 2013 - 2015

Evaluation of the nasal adjuvant activity of angiotensin peptide Ang-(1-7)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2015

Overcoming Immunosenescence by Nanoparticle-Mediated Activation

ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2014

Core C: Immunology

ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2009 - 2014

Development of Efficacious and Stable Nasal Vaccine Formulations

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2014

Sublingual Immunotherapy for Peanut Allergy

ResearchCo Investigator · Awarded by National Institutes of Health · 2008 - 2013

Nasal adjuvant to enhance anti-cocaine vaccines

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2011 - 2013

Enterotoxin targeting and delivery mechanisms

ResearchCollaborator · Awarded by National Institutes of Health · 2006 - 2012

Understanding the Mechanism of Mucosal Immunotherapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2012

Development of Efficacious Vaccine Against UTI's

ResearchCo Investigator · Awarded by National Institutes of Health · 2008 - 2011

Nasal Vaccines: Mode of Action, Composition & Delivery

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2011

Small cationic antimicrobial peptides: activators of innate & adaptive immunity

ResearchCo-Program Leader · Awarded by National Institutes of Health · 2008 - 2010

Alternative Endpoints for Plague Challenge Models

ResearchConsultant · Awarded by National Institutes of Health · 2004 - 2008

Novel Oral Adjuvant for Dental Vaccines

ResearchCo Investigator · Awarded by National Institutes of Health · 2004 - 2008

Mast Cell Activator as Adjuvant for Biodefense Vaccines

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2005 - 2007

A Universal Env Immunogen for all HIV-1 Subtypes

ResearchCo Investigator · Awarded by National Institutes of Health · 2003 - 2006

NCRR FACSAria Cell Sorter

EquipmentCo Investigator · Awarded by National Center for Research Resources · 2004 - 2006

Detection of in vivo ETEC vesicle production

ResearchInvestigator · Awarded by National Institutes of Health · 2003 - 2006

Immunogenicity of an HIV virus-like particle vaccine

ResearchInvestigator · Awarded by National Institutes of Health · 2003 - 2006

Epitope specificity of vaccine-induced anti-HIV IgG and IgA

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2003

Aids Research

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1989 - 2002

External Relationships


  • Mastezellen Bio Inc.
  • NIH
  • Vaccine Injury Compensation Program https://www.hrsa.gov/vaccine-compensation/index.html

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.